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It is known that calcium-phosphate (Ca-P) coatings are able not only to improve the bone
bonding behaviour of polymeric materials, but at the same time play a positive role on
enhancing cell adhesion and inducing the differentiation of osteoprogenitor cells. Recently
an innovative biomimetic methodology, in which a sodium silicate gel was used as a
nucleative agent, was proposed as an alternative to the currently available biomimetic
coating methodologies. This methodology is especially adequate for coating biodegradable
porous scaffolds. In the present work we evaluated the influence of the referred to
treatment on the mechanical properties of 50/50 (wt%) blend of corn starch/ethylene-vinyl
alcohol (SEVA-C) based scaffolds. These Ca-P coated scaffolds presented a compressive
modulus of 224.6 ± 20.6 and a compressive strength of 24.2 ± 2.20. Cytotoxicity evaluation
was performed according ISO/EN 10993 part 5 guidelines and showed that the biomimetic
treatment did not have any deleterious effect on L929 cells and did not inhibit cell growth.
Direct contact assays were done by using a cell line of human osteoblast like cells (SaOS-2).
3 × 105 cells were seeded per scaffold and allowed to grow for two weeks at 37 ◦C in a
humidified atmosphere containing 5% CO2. Total protein quantification and scanning
electron microscopy (SEM) observation showed that cells were able to grow in the
pre-mineralized scaffolds. Furthermore cell viability assays (MTS test) also show that cells
remain viable after two weeks in culture. Finally, protein expression studies showed that
after two weeks osteopontin and collagen type I were being expressed by SaOS-2 cells
seeded on the pre-mineralized scaffolds. Moreover, alkaline phosphatase (ALP) activity was
higher in the supernatants collected from the pre-mineralized samples, when compared to
the control samples (non Ca-P coated). This may indicate that a faster mineralization of the
ECM produced on the pre-mineralized samples was occurring. Consequently, biomimetic
pre-mineralization of starch based scaffolds can be a useful route for applying these
materials on bone tissue engineering.
C© 2005 Springer Science + Business Media, Inc.
1. Introduction
Reconstruction of extensive orthopaedic bone defects
is still a major problem affecting millions of peo-
ple world-wide, which contemporary medicine has yet
to solve. Besides the use of non-degradable prosthe-
sis, common therapeutics are focused on the use of
bone autografts. These present a series of disadvan-
tages such as limited availability, risk of infection, in-
creased blood loss and morbidity of the donor site [1–
3].
Tissue engineering has been emerging as a valid ap-
proach to circumvent the limitations of the described
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therapies. In this approach, osteogenic cells obtained
from the patient are implanted onto temporary 3D
biodegradable porous structures (scaffolds). This struc-
ture acts as a temporary physical support to guide new
tissue regeneration, until the entire material matrix is
totally degraded and up taken by the neo tissue. Ideally
these temporary scaffolds should be porous in order
to accommodate cell growth and facilitate both tissue
regeneration and vascularization [4–6]. Furthermore,
they should also be biocompatible, mechanically strong
and have a biodegradation rate similar to the cell/tissue
growth rates [4–6]. Still regarding bone tissue
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engineering three more properties should be consid-
ered: (i) the material should establish a stable direct con-
nection, both structural and functional, with the patients
bone [7], and the material should be (ii) osteoinductive
and (iii) osteoconductive, for recruitment of mesenchy-
mal progenitor cells and guided bone deposition on the
scaffolds surface [8].
If considering these three last key points, cal-
cium phosphate bioceramics would be the ideal
materials. Within these hydroxyapatite (HA) and
β-tricalcium phosphate (β-TCP), are excellent can-
didates for bone regeneration because their chemical
compositions are similar to the inorganic components
of human bone. When implanted in vivo these mate-
rials bind to bone trough a bone like apatite layer at
the interface or bind directly to bone [6]. Moreover,
they have also shown to be osteoconductive [8]. How-
ever, porous calcium phosphate bioceramics are very
brittle, which limits their mechanical properties and
hence their use in any type of load bearing situation
[5, 6].
Biodegradable polymers are an alternative to the ma-
terials discussed above. However, typically, they do
not present adequate bone bonding, osteoconductive
and osteoinductive properties. One existing solution to
overcome this problem is the deposition of a calcium-
phophate (Ca-P) layer, with a composition similar to
the inorganic component (HA) of bone, on the sur-
face of the polymeric 3D porous structures. After the
deposition, materials should exhibit better bone bond-
ing behaviour, as well as, better cell adhesion, prolif-
eration and differentiation profiles of osteoprogenitor
cells. This behaviour have been previously obtained by
different authors such as Zhang et al. [7], ter Brugge
et al. [9], Hulshoff et al. [10], Chang et al. [11] and
Ong et al. [12].
Starch based biodegradable materials have been re-
cently proposed for a wide range of biomedical bone
related applications, including bone tissue engineer-
ing scaffolding [13–16]. In order to improve the cell
adhesion to the materials, and in spite of all the dif-
ficulties arising from the pH changes and continuous
degradation of substrate surface, a series of biomimetic
Ca-P coating methodologies were developed. These
techniques allow the deposition of a Ca-P layer on
the surface of biodegradable starch based polymers
[17–19]. As it was reported by Oliveira et al. [18, 19]
these methodologies produce a partially amorphous Ca-
P coating that is similar to natural HA. They were suc-
cessfully applied on both compact and porous structures
for bone tissue engineering scaffolding applications.
One of such methodologies is based on the use of
sodium silicate gel as an alternative nucleating agent.
This agent is applied before the immersion in a simu-
lated body fluid (SBF) solution to promote apatite nu-
cleation and growth [19]. With this method, it is possi-
ble to diminish the incubation period for the formation
of an apatite coating, when compared to the traditional
biomimetic routes, which use bioactive glass particles
as nucleating agents [17]. This methodology is also es-
pecially adequate to coat uniformly the surface and the
bulk of porous scaffolds.
The present study reports on the biological response
(cytotoxicity, cell adhesion and protein expression) of
human osteoblast like cells to previously mineralized
starch based scaffolds. The influence of the already re-
ferred biomimetic treatment on the mechanical proper-
ties of the native material was also addressed. Results
showed that the Ca-P coatings were non toxic. More-
over the growth rate of human osteoblast like cells was
similar between the non coated and biomimetic coated
samples. Alkaline phosphatase levels were higher in the
Ca-P coated samples, which may indicate that the coat-
ings may be affecting the protein and gene expression
profile of human osteoblast like cells.
2. Materials and methods
2.1. Scaffolds production
and pre-mineralization
The polymer used in the present study was a
50:50 (wt%) blend of corn starch/ethylene-vinyl al-
cohol (SEVA-C, Novamont, Italy). Scaffolds were ob-
tained by using a technology based on extrusion with
blowing agents, previously described by Gomes et al.
[13]. Briefly, after being processed, scaffolds were cut
in 5 × 5 × 5 mm3 cuboids, after which the process of
pre-mineralization was started. For that purpose sam-
ples were soaked in a commercially available sodium
silicate solution (Sigma Aldrich, USA) for 24 h, in the
end of which samples were allowed to dry and im-
mersed in a simulated body fluid solution (SBF) for 14
days, as described previously [18, 19].
2.2. Scaffolds characterization
Calcium-phosphate layer formation, as well as its mor-
phology, were characterized by scanning electron mi-
croscopy (SEM) in a Leica Cambridge S360 (Leica
Cambridge, UK) equipment. All the samples were
previously gold coated in a Sputter Jeol JFC 1100
equipment.
Mechanical properties of the porous structures
were carried out in order to evaluate if the referred
biomimetic treatments had any effect on the mechani-
cal stability of the scaffolds. Mechanical compressive
experiments were carried out in an Instron 4505 univer-
sal testing machine (Instron, USA), using a load cell of
50 kN. Samples (n = 6) were previously cut in cylin-
ders with 1.5 mm of diameter by 1cm of height. The
compression tests were carried out at a crosshead speed
of 2 mm/min (4.7 × 10−5m/s), until fracture or obtain-
ing a maximum reduction in samples’ height of 60%.
Non-treated samples (n = 6) were used as controls.
2.3. Cytotoxicity assays
The cytotoxicity of the developed Ca-P coatings was
evaluated according to ISO/EN 109935 guidelines [20]
namely short MEM extraction and MTS tests, both
using a 24 h extraction period. Culture medium with
no extraction material and latex rubber were used,
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respectively, as negative and positive controls. Further-
more, and in order to evaluate if the treatments caused
any deleterious effects on the materials properties, non-
coated SEVA-C scaffolds were also used.
Cells selected for the present experiment were a cell
line of rat fibroblasts—L929, obtained from the Euro-
pean Collection of Cell Cultures (ECACC). Cells were
grown as monolayer cultures in Dulbecco’s modified
eagle medium (DMEM, Sigma, USA) supplemented
with 10% Foetal bovine Serum (FBS, Biochrome,
Germany) and 1% of antibiotics/antimicotics solution
(Sigma), and trypsinized before the experiments. For
the MEM extraction tests, cells were seeded in 24 well
plates, at a density of 1.25 × 105 cells (n = 3). For the
MTS test, cells were seeded in 96 well plates (n = 6), at
a density of 2 × 104 cells/well. In both cases, cells were
previously incubated for 24 h at 37 ◦C in a humidified
atmosphere containing 5% CO2.
Regarding the MEM extraction test, in all experi-
ments a constant ratio of material weight/extract fluid
of 0.2 g/ml was used, while for positive control the ratio
material outer surface/extraction fluid was 2.5 cm2/ml.
Tested material (n = 6), non-coated SEVA-C scaffolds
(n = 6) and positive control (latex rubber) (n = 6)
were extracted during 24 h under constant agitation at
60 rpm and 37 ◦C, with complete culture medium as the
extraction fluid. For the beginning of the tests, the cul-
ture medium in each well was replaced with the same
amount, 2 ml, of extraction fluid. The extracts of each
material were evaluated in three-fold. After adding the
extraction fluid the plates were incubated at 37 ◦C in a
humidified atmosphere containing 5% CO2. After 24,
48, and 72 h the reaction of the cells to the extracts
was evaluated microscopically, compared to the nega-
tive control and scored for the confluency of the mono-
layer, degree of floating cells and changes in cellular
morphology (see scores on Table I).
At the end of the test (after 72 h) cells were
trypsinized and the percentage of growth inhibition was
determined by counting cells using the trypan blue ex-
clusion test. Finally, the scores correspondent to the
above referred parameters were combined (the four pa-
rameters have been given an equal weight, i.e., 25%),
resulting in a final cytotoxicity index ranging from 0 to
8 (Table II).
TABL E I Quantitative and qualitative scores used in the cytotoxicity
tests
Floating Change of Inhibition
Confluency cells cellular of cell
Score (%) cells (%) morphology % growth (%)
0 100 0 No changes during 0–10
test period
1 90–100 0–5 Slight changes, few 10–30
cells affected
2 60–90 5–10 Mild changes, some cells 30–50
round/spindle shaped
3 30–60 10–20 Moderate changes, many 50–70
cells round/spindle
4 0–30 > 20 Severe changes, about all 70–100
show morphological
changes
TABLE I I Cytotoxicity index
Cytotoxicity index Reactivity Score
0–1 None Pass
1–3 Slightly toxic Pass
3–5 Mildly toxic Retest
5–7 Moderately toxic Fail
7–8 Severely toxic Fail
The grading system was as follows: For cytotoxicity
index ranging from 0 to 3, the material is considered to
pass the cytotoxicity test, for index between 3 and 5 is
advised to repeat the test and for index higher than 5
the material is considered to fail the test.
CellTiter 96©R One solution Cell proliferation Assay
kit (Promega, USA) is based on the bioreduction
of the substrate, (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazo-
lium) (MTS), into a brown formazan product by dehy-
drogenase enzymes in metabolically active cells, being
commonly used for cell viability evaluation [15, 16].
This assay followed the same extraction procedure de-
scribed previously for the MEM test, using 200 µl of
extraction fluid/well. After 72 h, the extract fluid was
removed and 200 µl of a mixture containing culture
medium without FBS and phenol red, and MTS were
added into each well. Cells were then incubated for
3 h at 37 ◦C in a humidified atmosphere containing 5%
CO2, in the end of which optical density (O.D.) was
measured in a multi-well plate reader (Molecular De-
vices, USA) at 490 nm. The mean O.D. 490 nm value
obtained for the negative control was standardized as
0% of metabolism inhibition.
2.4. Direct contact assays
2.4.1. Cell seeding
For direct contact assays a cell line of human osteoblast
like cells, SaOS-2, was selected. Cells were grown as
monolayer cultures in DMEM medium supplemented
with 10% FBS, 1% antibiotics/antymicotics solution, 5
mM β-glycerophosphate (Sigma, USA) and 50 µM of
ascorbic acid (Sigma, USA) up to the 10th passage. At
that time cells were trypsinized, centrifuged and resus-
pended in complete culture medium. Aliquots of 20 µl
containing 3 × 105 cells were then seeded on top of each
pre-mineralized scaffold. Two hours after cell seeding
1 ml of culture medium was added into each well and
cells/scaffolds constructs were incubated for 2 weeks at
37 ◦C in a humidified atmosphere containing 5% CO2,
with medium changes every 3–4 days. Uncoated scaf-
folds were used as controls.
2.4.2. Cell adhesion
Cell adhesion to pre-mineralized and non-mineralized
starch based scaffolds was assessed after 1, 7 and 14
days. For that purpose cells/scaffolds constructs were
first washed in 0.15 M PBS, fixed in 2.5% glutaralde-
hyde solution in PBS, submitted to a ethanol series
of 50, 70, 80, 90 and 100% for 2 × 15 min, and fi-
nally washed once again in PBS. Samples were then
gold coated in a Sputter Jeol JFC 1100 equipment and
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observed under a Leica Cambridge S360 scanning elec-
tron microscope.
2.4.3. Cell viability assay
Cell viability was assessed after 12 h, 7 and 14 days
by using the MTS test as described previously [15,
16]. Cells/scaffolds contructs (n = 6) were washed in
0.15 M PBS and placed in a mixture containing com-
plete culture medium (without FBS) and MTS in a 5:1
ratio and incubated for 3 h at 37 ◦C in a humidified at-
mosphere containing 5% CO2. After 3 h O.D. was read
at 490 nm. Results are presented as O.D./scaffold.
2.4.4. Cell proliferation assay
Cell proliferation of SaOS-2 cells on the pre-
mineralized and non mineralized starch based scaffolds
was assayed after 12 h, 7 and 14 days by a total pro-
tein assay, the Sedmak method, as described previously
[16]. Briefly, at each time point cells/scaffolds con-
structs were washed in 0.15 M PBS, placed in 750 µl of
lysis buffer (20 mM Tris, 1 mM EDTA, 150 mM NaCl
and 1% Triton X-100) supplemented with 100 µM
phenylmethylsulfonyl fluoride (PMSF, Sigma, USA)
and a cocktail of proteinase inhibitors (Chymostatin,
Leupeptin, Antipain, Pepstatin) in a final concentration
of 1 mg/ml, and finally sonicated at 40 Kv for 3 × 15 s.
Protein extracts were then submitted to a centrifugation,
after which the pellets were rejected. Scaffolds without
cells, but in the same culture conditions were used as
blanks. Finally 20 µl of the protein extracts were added
to 2 ml of Sedmak reagent and the O.D. read at 620 nm.
The results were then plotted against a standard curve
made with bovine serum albumin (BSA) ranging from
0 to 25 µg. Total protein was finally calculated by ex-
trapolation for the 750 µl of protein extract solution.
Results are shown as total protein/scaffold.
2.4.5. Alkaline phosphatase activity
Alkaline phosphatase (ALP) activity from the scaf-
folds/cells constructs was quantified by the specific
conversion of p-nitrophenyl phosphate (pNPP) into
para-nitrophenol (pNP). Supernatants were collected
after 12 h, 7 and 14 days (n = 6), frozen at −20 ◦C and
then thawed prior to analysis. The enzyme reaction was
set up by mixing 50 µl of the sample with 150 µl of sub-
strate buffer containing 1 M Diethanolamine HCL (pH
9,8) and 2 mg/ml of pNPP. The solution was incubated
at 37 ◦C for 30 min and the reaction was then stopped
by a solution containing 2 M NaOH and 0.2 mM EDTA
in distilled water. The optical density was determined
at 405 nm with a reference filter at 620 nm. A standard
curve was made using pNP values ranging from 0 to 0.6
µmol/ml. Results are shown in U/µg protein/scaffold.
2.4.6. Western immunoblot analysis
For western immunoblot analysis, protein was extracted
after 7 and 14 days and quantified as described in 2.4.4.
Aliquots containing equal amounts of protein (20 µg)
were submitted to an electrophoresis and then elec-
trotransferred to a Hybond P membrane (Amersham,
USA). After blocking the membranes, blots were then
further incubated for 1 h, at room temperature, with
primary antibodies against osteopontin (University of
Iowa, USA) and collagen I (Southern Biotechnology
Associates, USA) both in a 1:200 dilution. After wash-
ing, blots were further incubated for 1 h with anti-mouse
IgG antibody (Amersham, USA), for anti-osteopontin
blots, and anti-goat IgG antibody (Pierce, USA) for col-
lagen blots, both coupled to horse radish peroxidase.
The immune complex was then detected by incuba-
tion with ECL system (Amersham) and visualized by
chemiluminescence.
2.5. Statistics
Results are expressed as mean values ± standard devi-
ation for each group of samples. Statistical evaluation
was performed using two-tailed paired t student tests
to assess statistical differences between the different
groups. Statistical significance was defined as p < 0.05
for a 95% confidence interval.
3. Results and discussion
3.1. Scaffolds characterization
As it was recently reported by Oliveira et al. [19],
the biomimetic coating methodology described in the
present work allows for the formation of a partially
amorphous Ca-P layer, with Ca-P ratios similar to those
found on human bone natural occurring HA, on the sur-
face of starch based biodegradable scaffolds.
SEM observation demonstrated that the methodol-
ogy was effective to coat both the surface and the bulk
of the scaffolds. This data can be observed in Fig. 1, in
which it can be seen that both the bars of the scaffolds
(Fig. 1(d)) and the inner walls of the pores (Fig. 1(e)
and (f)) were coated. Furthermore, this same set of re-
sults showed that the referred to treatment did not affect
the pore size and the porosity. This property is partic-
ularly important due to the importance of porosity for
cell growth and viability, as well as for vascular vessels
ingrowth.
Further important data that resulted from the present
experiment indicated that the mechanical properties of
the material were not deleteriously affected. As it can
be seen in Fig. 2, mechanical properties of the modified
3D porous structures were improved when compared to
those of the control samples (Figs. 2 and 3) (p < 0.05).
These results are probably connected with the deposi-
tion of the Ca-P layer on the scaffolds. As it is known
this is a ceramic and hence can increase the mechanical
properties of the materials that are being used. How-
ever, this fact by itself would not be responsible for
such a significant difference between the coated and
non-coated. In this sense it is also believed that the
leaching of a small amount of plasticizer during the
SBF immersion time may also have a minor role on the
increase of the mechanical properties. At the same time
mechanical properties were also similar to those found
for trabecular bone, showing that the developed coated
scaffolds may have enough mechanical stability to be
used for bone tissue engineering purposes.
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Figure 1 Scanning electron microscopy observation of starch based scaffolds after 14 days immersion in a simulated body fluid (SBF) solution: (a),
(b), (c) non treated samples; (d), (e), (f), treated with a sodium silicate gel solution as a nucleative agent. Notice that the treatment did not close the
pores and did not affect the interconnectivity of the porous scaffolds. Moreover, the walls of the pores were also effectively coated with a Ca-P layer
(e, f), being demonstrated that by using this technique it is possible to coat both the surface and the bulk of the scaffold.
Figure 2 Compressive modulus of non-treated (control) and sodium sil-
icate treated (BMT) after 14 days of immersion in a SBF solution (n = 6,
± sd; *p < 0.05).
3.2. Cytotoxicity assays
Regarding short-term MEM extraction tests, the re-
sults demonstrated that leachables from the Ca-P coated
Figure 3 Compressive strength of non-treated (control) and sodium sili-
cate treated (BMT) after 14 days of immersion in a SBF solution (n = 6,
± sd; *p < 0.05).
samples did not cause growth inhibition after 72 h,
having similar results to those obtained for the non-
coated samples. As it is shown in Fig. 4 cells incu-
bated with the extracts from the Ca-P coated samples
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Figure 4 L929 cells incubated with extracts obtained from (a) negative control, (b) positive control, (c) untreated SEVA-C scaffolds and (d) biomimetic
treated SEVA-C scaffolds, over a 72 h period. (100× magnification)
presented minor alterations in their morphology when
compared with both the negative control and the non-
coated SEVA-C samples (Fig. 4(a), (c), and (d)). These
alterations are probably related with the slightly higher
proliferation indexes of both the negative control and
non-coated SEVA-C samples, which lead the latter to
higher degrees of confluence. After the combination of
the several scores, as referred in the materials and meth-
ods section, the tested material had a cytotoxic index
of 0.2 (Table III). These results are not typical at all of
biodegradable polymers that are currently being used
within the bone tissue engineering field.
Regarding MTS test, L929 cells produced large
amounts of a brown formazan product, which indicates
strong MTS reduction and high metabolic rates by the
cells (Fig. 5). The results obtained were similar to those
of negative control and non-coated samples. This fact
clearly indicates that the developed Ca-P coated 3D
porous structures not only were non toxic but they also
did not cause any deleterious alteration on the raw ma-
terial.
As a conclusion, and after combining the results from
both the MEM extraction and MTS tests, it can clearly
TABL E I I I Short MEM extraction test cytotoxicity results
Sample Cytotoxixity index
SEVA-C Ca-P coated 0.2
SEVA-C Non-coated 0.1
Figure 5 MTS reduction by L929 cells after incubation with the test
and positive control extracts over a period of 72 h. Results are based
on optical density measurements and were normalized for the negative
control.
be stated that the leachables from SEVA-C scaffolds
coated with a Ca-P layer are not harmful to the cells.
Therefore, the materials can be considered as being non
cytotoxic.
3.3. Direct contact assays
The initial in vitro interaction between cells and a cer-
tain biomaterial is commonly mediated by a previously
adsorbed layer of protein resultant from cell culture
medium [21, 22]. However, within the present study a
new factor was introduced, a Ca-P layer. In this context
cells will interact with a Ca-P layer and the proteins
adsorbed on it. This fact may affect not only the pat-
tern of adhesion of osteoblast like cells to the material,
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Figure 6 Scanning electron microscopy (SEM) of SaOS-2 cell adhesion and proliferation on non treated (a) and biomimetic treated (b) SEVA-C
based scaffolds after 14 days in culture.
but also reorganisations in their cytoskeleton as well as
different gene expression profiles [23–25].
Regarding the present experiment, SEM observation
showed that cells were already well adhered to the mate-
rial after just one day in culture (data not shown), being
present mainly on the cell walls of the porous scaffold.
However, some differences concerning cell morphol-
ogy could already be detected. Human osteoblast like
cells had a more spread and flattened morphology than
those seeded on the non-coated samples, which indi-
cates a stronger cellular adhesion (data not shown). Af-
ter day 1, cells start to grow and colonize both the Ca-P
coated and control scaffolds. By the end of the first (data
not shown) and second week of the experiment the de-
gree of colonization of the scaffolds was higher and
some of the pores were already been taken up by some
cells (Fig. 6). At the same time multi-layered skeletal
structures, typical of extracellular matrix (ECM) depo-
sition, were found in cells colonizing the inner pores of
the Ca-P coated scaffolds. The same differences in the
morphology registered just after one day in culture were
also observed after 1 (data not shown) and 2 weeks (Fig.
6). As it can be observed in Fig. 6 osteoblast-like cells
presented different morphologies when in contact with
the surface of the two different scaffolds. Although they
were able to adhere and grow on both substrates, SaOS-
2 cells seeded onto the Ca-P coated scaffold seemed to
have undergone a different cytoskeletal rearrangement
presenting a more flattened and spread morphology (ar-
rows), when compared to the cells seeded on the control
samples (arrows). These results prove that the phenom-
ena observed just after 1 day in culture was not acci-
dental. This fact is coherent when compared with the
data found in the literature [10]. Previous studies had
already shown that when in contact with Ca-P coatings
osteogenic cells not only seem to have better adhesion
patterns, but would also undergo cytoskeleton reorgan-
isation, presenting different morphologies when com-
pared to non-coated samples [6, 9, 12].
Total protein results (Fig. 7) showed that cells were
able to proliferate within both coated and uncoated sam-
ples. However, the values obtained for Ca-P coated sam-
ples were always smaller when compared to the control,
being the differences significative different after 12 h
(p < 0.05) and 14 days (p < 0.05). These differences
are mainly related with two factors. Firstly, samples,
Figure 7 Cell proliferation was weekly assessed by means of a total
protein assay. Cell density used was 3 × 105 cells/scaffold (Ct—non-
treated samples; BMT—biomimetic treated samples). Cells were kept in
culture for 14 days in complete culture medium supplemented with 5 mM
β-glycerophosphate, 50 µM ascorbic acid (n = 6, ± sd; *p < 0.05).
which suffer the sodium silicate and biomimetic treat-
ments, were slightly more hydrophobic than the control
samples. Because of this, their capability of absorbing
the cell suspension was diminished and so, the amount
of cells that was able to adhere to the modified scaffolds
was smaller. The second reason by which the growth
was smaller on the Ca-P coated samples during the sec-
ond week of growth is probably related with the depo-
sition of extracellular matrix or its mineralization, as it
will be discussed later.
Cell viability assays (MTS test) showed that cells
remained viable for the two weeks of the experiment,
with increasing metabolic rates (Fig. 8), which are as-
sociated with an increasing cell number. Differences
on the O.D. values were found to be significant after
12 h (p < 0.05) (higher O.D. for control samples) and
7 days (p < 0.05) (higher O.D. for treated samples),
and non significative after 14 days (p > 0.05). Regard-
ing the differences obtained for just after 12 h they are
related with the higher hydrophobicity of the treated
samples as described earlier. The differences registered
for the first week are mainly related with the different
growth rates of the cells. When analysing the data from
total protein, it is clear that cells seeded on the modified
samples had a faster growth rate when compared to the
control. Because of this, it is logical that the overall
metabolic rate was increased and hence the amount of
MTS incorporated and reduced by the cells was higher
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Figure 8 Cell viability was weekly assessed by means of MTS test.
Cell density used was 3 × 105 cells/scaffold (Ct—non-treated sam-
ples; BMT—biomimetic treated samples). Cells were kept in culture
for 14 days in complete culture medium supplemented with 5 mM β-
glycerophosphate, 50 µM ascorbic acid (n = 6, ± sd; *p < 0.05).
in those that were growing in the modified scaffolds.
Finally, and after two weeks of growth the O.D. val-
ues were similar. These values are once again related
with the growth rate of the cells as well as with other
phenomena such as matrix deposition and consequent
mineralization.
Western immunoblot analysis showed that osteopon-
tin and collagen I were being expressed by human os-
teoblast like cells seeded on both Ca-P coated and on
uncoated scaffolds.
Collagen I is the most abundant protein in bone
ECM. Together with other forms of collagen and bone
specific glycoproteins forms hydroxyapatite embedded
heterofibrils, that reveal unmatched mechanical prop-
erties concerning load bearing, tensile strength and tor-
sional resistance [26]. Furthermore, besides being in-
volved in the formation of mineralized bone matrix it
also involved in such important processes such as cell
adhesion, proliferation and differentiation of osteopro-
genitor cells [26, 27]. In this sense, it can be said that
the presence of collagen I is essential for the synthesis
of a solid and functional bone extracellular matrix.
Osteopontin, which was first described by Senger
et al. [28] as a secreted phosphoprotein, is another bone
extracellular constituent protein. As recently reviewed
by Sodek et al. [29], this protein is involved in several
processes that occur in remodelling bone such as cell
adhesion, bone resorption, the bridging between cells
and HA, and between bone matrix and mineral, as well
as bone matrix mineralization. In vitro, its expression
is also detected and it is commonly associated with the
formation of a collagen-free cement layer upon which
bone is subsequently deposed. When observing Fig. 9
it is clearly seen that osteopontin was expressed after 1
and 2 weeks, while collagen I expression was only de-
tected after two weeks. Together with the data observed
by SEM (Fig. 6), these results indicate that active bone
extracellular matrix deposition was occurring.
ALP is a membrane-bound enzyme that hydrolyses
phosphate esters, being also secreted into the extracellu-
lar millieu. It is commonly referred as an initial marker
of the osteogenic phenotype and it is involved in the
initial processes of bone extracellular matrix mineral-
ization [30].
Figure 9 Western blot analysis of collagen I (a, b) and osteopontin (c, d)
expression of SaOS-2 cells seeded on starch based scaffolds (Ct—non-
treated samples, BMT—biomimetic treated samples) after 1 (a, c) and 2
weeks (b, d) respectively. Expression of the referred proteins indicates
the deposition of bone extracelullar matrix (ECM).
Figure 10 ALP actvity assay: supernatants were weekly collected and
frozen. After 2 weeks supernatants were thawed. The results are shown
in U/µg protein/scaffold in function of days. (n = 6, ± sd; *p < 0.05;
Ct—control and BMT—biomimetic treated).
Regarding the present experiment, ALP activity ex-
periments showed that after two weeks the activity
of this enzyme was higher, and significantly differ-
ent (p < 0.05), in the supernatants collected from the
Ca-P cells/scaffolds constructs. This fact indicates that
a faster mineralization of the extracellular matrix de-
posited on the Ca-P coated scaffolds was happening.
Furthermore, it also shows why the growth was smaller
during the second week. The onset of matrix mineral-
ization (calcium and phosphate deposition) is regularly
associated with a decrease on cell proliferation [31, 32].
The different ALP activity profiles are probably re-
lated with the cristallinity degree or the roughness of
the Ca-P layer deposed. Studies by ter Bruge et al. [9]
have shown that the osteogenic phenotype of osteoblast
like cells was dramatically increased when these cells
were put in contact with Ca-P coated surfaces. Another
possible reason is the roughness of the Ca-P layer when
compared to the uncoated material. When cells are in
contact with rougher surfaces their cytoskeleton reorga-
nizes trough actin filaments rearrangement, which will
lead to a different gene expression profile [23–25, 33].
Finally, the dissolution products from the coatings can
also play a role in the upregulation of the osteogenic
phenotype, as described previously [9].
Nevertheless further studies should be conducted in
order to fully understand the mechanisms triggered by
the Ca-P coatings that were described in this work.
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4. Conclusions
The sodium silicate gel biomimetic coating methodol-
ogy proved to be very effective in the production of a
Ca-P layer on the surface of starch based biodegradable
scaffolds. Moreover this methodology did not cause
any alterations of the materials non-toxic behaviour,
as demonstrated by both MEM and MTS tests. Direct
contact assays showed that cells were able to prolif-
erate within the Ca-P layer of the modified scaffolds,
demonstrating its adequacy for cell growth. Finally pro-
tein expression studies clearly indicated that a faster
mineralization of the extracellular matrix was happen-
ing in the Ca-P cells/scaffolds constructs. This fact may
also indicate that these biomimetic coatings may be os-
teoinductive and therefore might be able to increase the
differentiation rate of human osteoblast like cells into
a more differentiated osteogenic phenotype, and con-
sequently could be useful for bone tissue engineering
applications.
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